[Experimental study of the effect of nonachlazine on the metabolism of the ischemic myocardium].
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy / Q000378:metabolism*; D003402:Creatine Kinase / Q000378:metabolism; D004285:Dogs; D003576:Electron Transport Complex IV / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D008274:Magnesium; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009628:Nonachlazine / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology*; D010762:Phosphorylase a / Q000378:metabolism; D010763:Phosphorylase b / Q000378:metabolism; D013385:Succinate Dehydrogenase / Q000378:metabolism; D013997:Time Factors
D010640:Phenothiazines; D009628:Nonachlazine; D013385:Succinate Dehydrogenase; D003576:Electron Transport Complex IV; D010762:Phosphorylase a; D010763:Phosphorylase b; D003402:Creatine Kinase; D000251:Adenosine Triphosphatases; D008274:Magnesium
Vliianie nonaklazina na metabolizm ishemizirovannogo miokarda v éksperimente.